Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata). (Q48630288)

13 February 2018

title

Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata). (English)

1 reference

13 February 2018

main subject

Black-tufted marmoset

0 references

0 references

4

1 reference

13 February 2018

author name string

Marilia Barros

series ordinal

1

1 reference

13 February 2018

M A De Souza Silva

series ordinal

2

1 reference

13 February 2018

Joseph P Huston

series ordinal

3

1 reference

13 February 2018

publication date

1 May 2002

1 reference

13 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Peptides

1 reference

13 February 2018

volume

23

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

967-973

1 reference

13 February 2018

Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Observational study of behavior: sampling methods

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Measuring fear and anxiety in the marmoset (Callithrix penicillata) with a novel predator confrontation model: effects of diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Behavioral effects of buspirone in the marmoset employing a predator confrontation test of fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Marmoset conspecific confrontation: an ethologically-based model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Aversive effects of the C-fragment of Substance P in the dorsal periaqueductal gray matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Comparison of neurokinin SP with diazepam in effects on memory and fear parameters in the elevated T-maze free exploration paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

An ethologically based, stimulus and gender-sensitive nonhuman primate model for anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Neurotransmitter functions of mammalian tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Short‐term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri‐aqueductal grey and limbic regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Measuring anxiety in nonhuman primates: effect of lorazepam on macaque scratching.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

Facilitation of memory by peripheral administration of substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900020-7

7 January 2021

10.1016/S0196-9781(02)00020-7

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

12084529

1 reference

13 February 2018